| David Dorsky, | |
|
263 Farmington Ave, Farmington, CT 06030-0001 | |
| (860) 679-4225 | |
| Not Available |
| Full Name | David Dorsky |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 263 Farmington Ave, Farmington, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922003649 | NPI | - | NPPES |
| 1298828 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 029882 (Connecticut) | Primary |
| Entity Name | Southcoast Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336137629 PECOS PAC ID: 0749171957 Enrollment ID: O20040920000138 |
News Archive
A laboratory study led by researchers at Dana-Farber Cancer Institute has shown that a potent and highly selective therapy for chronic myelogenous leukemia (CML) may ultimately be more effective than Gleevec®, the current standard of care.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of RG-125 (AZD4076), a GalNAc-conjugated anti-miR targeting microRNA-103/107 ("miR-103/107") for the treatment of Non Alcoholic Steatohepatitis ("NASH) in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca under the companies' strategic alliance to discover, develop and commercialize microRNA therapeutics.
On April 28, the Center for BrainHealth will bring together national experts to discuss solutions to our most pressing brain-related challenges at its inaugural Brain Health Summit, titled "The Human Brain: Resilience and Regeneration."
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Dorsky, 263 Farmington Ave, Provider Enrollment, Farmington, CT 06030-2212 Ph: (860) 679-7503 | David Dorsky, 263 Farmington Ave, Farmington, CT 06030-0001 Ph: (860) 679-4225 |
News Archive
A laboratory study led by researchers at Dana-Farber Cancer Institute has shown that a potent and highly selective therapy for chronic myelogenous leukemia (CML) may ultimately be more effective than Gleevec®, the current standard of care.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of RG-125 (AZD4076), a GalNAc-conjugated anti-miR targeting microRNA-103/107 ("miR-103/107") for the treatment of Non Alcoholic Steatohepatitis ("NASH) in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca under the companies' strategic alliance to discover, develop and commercialize microRNA therapeutics.
On April 28, the Center for BrainHealth will bring together national experts to discuss solutions to our most pressing brain-related challenges at its inaugural Brain Health Summit, titled "The Human Brain: Resilience and Regeneration."
The Kaiser Family Foundation's Policy Tracker provides information on proposed legislation released by the Senate Committee on Appropriations that would designate funding for the remainder of FY 2013, including funding for global health programs at the State Department and USAID under a Continuing Resolution (3/12).
› Verified 3 days ago
Maroun Sfeir, Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 263 Farmington Avenue, Farmington, CT 06030 Phone: 860-679-2980 Fax: 860-679-4334 | |
Andrew Arnold, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-3245 Fax: 860-679-1867 | |
Dr. Neelam Tailor, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-4763 Fax: 860-479-4624 | |
Dr. David K. Bowers, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06032 Phone: 860-679-4477 Fax: 860-679-1025 | |
Scott R Allen, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-4477 Fax: 860-679-1025 | |
Carl D Malchoff, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-3245 Fax: 860-679-1867 | |
Beatriz R Esayag-tendler, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-3343 Fax: 860-679-4256 |